Williams Jones & Associates’s GSK GSK Stock Holding History

Williams Jones & Associates’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,284	Closed	-$367K	–	457
2018 Q2	$367K	Sell	7,284 -240	-3%	-$12.1K	0.01%	323
2018 Q1	$367K	Hold	7,524	–	–	0.01%	320
2017 Q4	$334K	Sell	7,524 -80	-1%	-$3.7K	0.01%	341
2017 Q3	$386K	Buy	7,604 +1,204	+19%	+$61.1K	0.01%	312
2017 Q2	$345K	Sell	6,400 -1,980	-24%	-$106K	0.01%	319
2017 Q1	$442K	Hold	8,380	–	–	0.01%	287
2016 Q4	$403K	Sell	8,380 -400	-5%	-$19.8K	0.01%	293
2016 Q3	$473K	Hold	8,780	–	–	0.01%	276
2016 Q2	$476K	Buy	8,780 +5,600	+176%	+$295K	0.01%	269
2016 Q1	$161K	Buy	+3,180	New	+$158K	0.01%	311
2015 Q2	–	Sell	-3,500	Closed	-$202K	–	386
2015 Q1	$202K	Buy	+3,500	New	+$201K	0.01%	352
2014 Q4	–	Sell	-3,500	Closed	-$201K	–	394
2014 Q3	$201K	Hold	3,500	–	–	0.01%	310
2014 Q2	$234K	Sell	3,500 -78,858	-96%	-$5.34M	0.01%	292
2014 Q1	$5.5M	Buy	82,358 +78,752	+2,184%	+$5.32M	0.11%	127
2013 Q4	$241K	Hold	3,606	–	–	0.01%	267
2013 Q3	$226K	Sell	3,606 -27,665	-88%	-$1.78M	0.01%	268
2013 Q2	$1.95M	Buy	+31,271	New	+$1.98M	0.1%	135

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Williams Jones & Associates's GSK Position: Q3 2018 in Review

Williams Jones & Associates sold out of GSK (GSK) in Q3 2018, closing a stake of 7,284 shares — an estimated $367K sold.

Williams Jones & Associates first reported a position in GSK in Q2 2013 and held it in 17 quarters. The position peaked at $5.5M in Q1 2014. 787 funds tracked by Wall St. Rank hold GSK as of Q3 2018.

Williams Jones & Associates reported no remaining GSK position as of Q3 2018 after selling out during the quarter.
Williams Jones & Associates sold 7,284 GSK shares in Q3 2018, an estimated $367K.
Williams Jones & Associates first reported a position in GSK in Q2 2013 and held it in 17 quarters.
Williams Jones & Associates's GSK position peaked at $5.5M in Q1 2014.
787 funds tracked by Wall St. Rank held GSK as of Q3 2018.

Based on Williams Jones & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.